Skip to main content
Scholar Rock Holding Corp logo

Scholar Rock Holding Corp — Investor Relations & Filings

Ticker · SRRK ISIN · US80706P1030 LEI · 549300Z1FLPGL4OWJ459 US Professional, scientific and technical activities
Filings indexed 604 across all filing types
Latest filing 2024-06-18 Director's Dealing
Country US United States of America
Listing US SRRK

About Scholar Rock Holding Corp

https://scholarrock.com/

Scholar Rock Holding Corp. is a late-stage biopharmaceutical company that discovers, develops, and delivers therapies for serious diseases, with a focus on neuromuscular disorders. The company's scientific approach is centered on selectively targeting protein growth factors in their latent, inactive state. This proprietary platform aims to modulate biological functions with high specificity, representing a novel method compared to traditional approaches that target already activated proteins. Founded on pioneering research from Harvard Medical School and Boston Children's Hospital, Scholar Rock is developing a new class of medicines to address the underlying causes of disease.

Recent filings

Filing Released Lang Actions
Director's Dealing 2024
Director's Dealing
2024-06-18 English
Director's Dealing 2024
Director's Dealing
2024-06-18 English
Director's Dealing 2024
Director's Dealing
2024-06-18 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 3, 2024, by Scholar Rock Holding Corporation. It reports new clinical trial data presented at the ASCO 2024 Annual Meeting and announces a conference call to discuss these results. The document includes detailed clinical trial results and safety data, but it is not a full financial report or earnings release. It also includes exhibits such as a press release and presentation slides. The primary purpose is to disclose material events and updates outside of regular periodic reports. This fits the profile of a Regulatory Filing (RNS) as it is a current report disclosing material events pursuant to the Securities Exchange Act of 1934, rather than an earnings release, annual report, or other specific report type. The document length (8284 characters) and content confirm it is not a brief announcement or a full financial report but a detailed regulatory disclosure.
2024-06-03 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes an amendment to a loan agreement (a financing update), details about an upcoming Investor Day event with a business update and presentation slides, and announcements about clinical trial initiation and preclinical data. The document does not contain comprehensive financial statements or detailed financial performance data typical of Annual Reports (10-K) or Interim Reports (IR). It also is not a transcript, proxy statement, or legal proceeding report. The primary focus is on a material definitive agreement amendment (loan amendment) and business updates, which aligns best with Capital/Financing Update (CAP). The presence of the Investor Day presentation as an exhibit does not change the classification since the main document is a current report about financing and business updates. Therefore, the filing type is CAP with high confidence.
2024-05-22 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated May 14, 2024. It reports an amendment to a lease agreement, which is a material definitive agreement. The content is an announcement of a specific event (lease amendment) rather than a full financial report or earnings release. The document length is 3838 characters, which is relatively short and focused on a specific event. This fits the category of a Regulatory Filing (RNS), as it is a general regulatory announcement that does not fit into more specific categories like Annual Report, Earnings Release, or Capital Update. It is not a certification or a report publication announcement, but a current report on a material event.
2024-05-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.